Cite

    Kirch, N. et al. (2018). A nutritive dose of pure (–)-epicatechin does not beneficially affect increased cardiometabolic risk factors in overweight-to-obese adults—a randomized, placebo-controlled, double-blind crossover study. American journal of clinical nutrition. 107 (6), pp. 948-956. [Online].